Annual FCF
-$20.95 M
-$168.00 K-0.81%
December 31, 2023
Summary
- As of February 7, 2025, ATOS annual free cash flow is -$20.95 million, with the most recent change of -$168.00 thousand (-0.81%) on December 31, 2023.
- During the last 3 years, ATOS annual FCF has fallen by -$9.38 million (-80.97%).
- ATOS annual FCF is now -5751.72% below its all-time high of -$358.10 thousand, reached on December 31, 2010.
Performance
ATOS Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$4.76 M
-$226.00 K-4.98%
September 30, 2024
Summary
- As of February 7, 2025, ATOS quarterly free cash flow is -$4.76 million, with the most recent change of -$226.00 thousand (-4.98%) on September 30, 2024.
- Over the past year, ATOS quarterly FCF has dropped by -$876.00 thousand (-22.55%).
- ATOS quarterly FCF is now -849.13% below its all-time high of $635.40 thousand, reached on September 30, 2016.
Performance
ATOS Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$19.57 M
-$876.00 K-4.69%
September 30, 2024
Summary
- As of February 7, 2025, ATOS TTM free cash flow is -$19.57 million, with the most recent change of -$876.00 thousand (-4.69%) on September 30, 2024.
- Over the past year, ATOS TTM FCF has increased by +$346.00 thousand (+1.74%).
- ATOS TTM FCF is now -291974.63% below its all-time high of -$6700.00, reached on March 31, 2011.
Performance
ATOS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ATOS Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.8% | -22.6% | +1.7% |
| 3 y3 years | -81.0% | -55.0% | -20.4% |
| 5 y5 years | -131.0% | -55.0% | -20.4% |
ATOS Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -27.1% | at low | -29.9% | +32.2% | -18.7% | +14.6% |
| 5 y | 5-year | -129.4% | at low | -112.9% | +32.2% | -114.2% | +14.6% |
| alltime | all time | -5751.7% | at low | -849.1% | +32.2% | <-9999.0% | +14.6% |
Atossa Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$4.76 M(+5.0%) | -$19.57 M(+4.7%) |
| Jun 2024 | - | -$4.53 M(-3.6%) | -$18.69 M(+0.3%) |
| Mar 2024 | - | -$4.70 M(-15.6%) | -$18.64 M(-11.1%) |
| Dec 2023 | -$20.95 M(+0.8%) | -$5.57 M(+43.4%) | -$20.95 M(+5.2%) |
| Sep 2023 | - | -$3.88 M(-13.3%) | -$19.91 M(-7.1%) |
| Jun 2023 | - | -$4.48 M(-36.2%) | -$21.45 M(-6.4%) |
| Mar 2023 | - | -$7.02 M(+55.0%) | -$22.92 M(+10.3%) |
| Dec 2022 | -$20.79 M(+26.1%) | -$4.53 M(-16.3%) | -$20.79 M(+4.3%) |
| Sep 2022 | - | -$5.42 M(-9.0%) | -$19.92 M(+13.3%) |
| Jun 2022 | - | -$5.95 M(+21.6%) | -$17.58 M(+3.6%) |
| Mar 2022 | - | -$4.89 M(+33.5%) | -$16.96 M(+2.9%) |
| Dec 2021 | -$16.48 M(+42.3%) | -$3.67 M(+19.3%) | -$16.48 M(+1.4%) |
| Sep 2021 | - | -$3.07 M(-42.5%) | -$16.25 M(+2.5%) |
| Jun 2021 | - | -$5.34 M(+21.1%) | -$15.86 M(+24.3%) |
| Mar 2021 | - | -$4.41 M(+28.4%) | -$12.76 M(+10.2%) |
| Dec 2020 | -$11.58 M(+26.7%) | -$3.43 M(+28.0%) | -$11.58 M(+6.7%) |
| Sep 2020 | - | -$2.68 M(+19.9%) | -$10.86 M(+9.2%) |
| Jun 2020 | - | -$2.24 M(-30.8%) | -$9.94 M(-2.7%) |
| Mar 2020 | - | -$3.23 M(+19.3%) | -$10.22 M(+11.8%) |
| Dec 2019 | -$9.14 M(+0.7%) | -$2.71 M(+53.1%) | -$9.14 M(+2.3%) |
| Sep 2019 | - | -$1.77 M(-29.5%) | -$8.93 M(-5.6%) |
| Jun 2019 | - | -$2.51 M(+16.8%) | -$9.46 M(+7.7%) |
| Mar 2019 | - | -$2.15 M(-14.0%) | -$8.78 M(-3.2%) |
| Dec 2018 | -$9.07 M(+37.6%) | -$2.50 M(+8.6%) | -$9.07 M(+9.9%) |
| Sep 2018 | - | -$2.30 M(+25.5%) | -$8.26 M(+7.8%) |
| Jun 2018 | - | -$1.83 M(-24.8%) | -$7.66 M(+6.8%) |
| Mar 2018 | - | -$2.44 M(+44.9%) | -$7.17 M(+8.8%) |
| Dec 2017 | -$6.59 M | -$1.68 M(-1.1%) | -$6.59 M(+5.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | -$1.70 M(+26.2%) | -$6.27 M(+59.4%) |
| Jun 2017 | - | -$1.35 M(-27.5%) | -$3.93 M(-7.3%) |
| Mar 2017 | - | -$1.86 M(+36.8%) | -$4.25 M(-21.2%) |
| Dec 2016 | -$5.38 M(-61.8%) | -$1.36 M(-314.1%) | -$5.38 M(-33.0%) |
| Sep 2016 | - | $635.40 K(-138.3%) | -$8.04 M(-34.1%) |
| Jun 2016 | - | -$1.66 M(-44.7%) | -$12.21 M(-13.2%) |
| Mar 2016 | - | -$3.00 M(-25.3%) | -$14.06 M(-0.2%) |
| Dec 2015 | -$14.08 M(+31.4%) | -$4.02 M(+13.7%) | -$14.08 M(+11.2%) |
| Sep 2015 | - | -$3.53 M(+0.7%) | -$12.66 M(+3.8%) |
| Jun 2015 | - | -$3.51 M(+15.9%) | -$12.20 M(+10.6%) |
| Mar 2015 | - | -$3.03 M(+16.6%) | -$11.04 M(+3.0%) |
| Dec 2014 | -$10.72 M(+15.0%) | -$2.60 M(-15.6%) | -$10.72 M(-1.3%) |
| Sep 2014 | - | -$3.07 M(+31.2%) | -$10.86 M(+0.2%) |
| Jun 2014 | - | -$2.34 M(-13.5%) | -$10.84 M(+1.4%) |
| Mar 2014 | - | -$2.71 M(-1.1%) | -$10.68 M(+14.6%) |
| Dec 2013 | -$9.32 M(+131.0%) | -$2.74 M(-10.2%) | -$9.32 M(+9.5%) |
| Sep 2013 | - | -$3.05 M(+39.2%) | -$8.52 M(+51.6%) |
| Jun 2013 | - | -$2.19 M(+63.1%) | -$5.62 M(+32.5%) |
| Mar 2013 | - | -$1.34 M(-30.5%) | -$4.24 M(+8.7%) |
| Dec 2012 | -$4.03 M(+11.2%) | -$1.93 M(+1179.7%) | -$3.90 M(+27.5%) |
| Sep 2012 | - | -$151.00 K(-81.4%) | -$3.06 M(-28.3%) |
| Jun 2012 | - | -$811.50 K(-19.3%) | -$4.27 M(-7.8%) |
| Mar 2012 | - | -$1.01 M(-7.8%) | -$4.63 M(+27.5%) |
| Dec 2011 | -$3.63 M(+913.5%) | -$1.09 M(-19.8%) | -$3.63 M(+42.9%) |
| Sep 2011 | - | -$1.36 M(+16.0%) | -$2.54 M(+115.3%) |
| Jun 2011 | - | -$1.17 M(>+9900.0%) | -$1.18 M(>+9900.0%) |
| Mar 2011 | - | -$6700.00 | -$6700.00 |
| Dec 2010 | -$358.10 K | - | - |
FAQ
- What is Atossa Therapeutics annual free cash flow?
- What is the all time high annual FCF for Atossa Therapeutics?
- What is Atossa Therapeutics annual FCF year-on-year change?
- What is Atossa Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Atossa Therapeutics?
- What is Atossa Therapeutics quarterly FCF year-on-year change?
- What is Atossa Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Atossa Therapeutics?
- What is Atossa Therapeutics TTM FCF year-on-year change?
What is Atossa Therapeutics annual free cash flow?
The current annual FCF of ATOS is -$20.95 M
What is the all time high annual FCF for Atossa Therapeutics?
Atossa Therapeutics all-time high annual free cash flow is -$358.10 K
What is Atossa Therapeutics annual FCF year-on-year change?
Over the past year, ATOS annual free cash flow has changed by -$168.00 K (-0.81%)
What is Atossa Therapeutics quarterly free cash flow?
The current quarterly FCF of ATOS is -$4.76 M
What is the all time high quarterly FCF for Atossa Therapeutics?
Atossa Therapeutics all-time high quarterly free cash flow is $635.40 K
What is Atossa Therapeutics quarterly FCF year-on-year change?
Over the past year, ATOS quarterly free cash flow has changed by -$876.00 K (-22.55%)
What is Atossa Therapeutics TTM free cash flow?
The current TTM FCF of ATOS is -$19.57 M
What is the all time high TTM FCF for Atossa Therapeutics?
Atossa Therapeutics all-time high TTM free cash flow is -$6700.00
What is Atossa Therapeutics TTM FCF year-on-year change?
Over the past year, ATOS TTM free cash flow has changed by +$346.00 K (+1.74%)